Trial Outcomes & Findings for A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer (NCT NCT02182804)
NCT ID: NCT02182804
Last Updated: 2020-08-28
Results Overview
Diagnostic performance of the pCLE and M-NBI in Lugol's voiding lesions size larger than 5 millimeters.
COMPLETED
NA
44 participants
an expected average of 2 weeks
2020-08-28
Participant Flow
There were 631 patients with a previous history of head and neck cancer in the 10-year record. Of the 631 patients, 587 were excluded for the following reasons: patients could not be contacted (n=458), death (n=72), esophageal obstruction or stricture, previous esophageal surgery (n=34), and patients who refused to participate (n=23).
Participant milestones
| Measure |
Study Arm
Probe-based confocal laser endomicroscopy and narrow band imaging with magnification in esophageal Lugol's voiding lesions.
|
|---|---|
|
Overall Study
STARTED
|
44
|
|
Overall Study
COMPLETED
|
44
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Study Arm
n=44 Participants
Probe-based confocal laser endomicroscopy and narrow band imaging with magnification in esophageal Lugol's voiding lesions.
|
|---|---|
|
Age, Continuous
|
60 years
STANDARD_DEVIATION 12 • n=44 Participants
|
|
Sex: Female, Male
Female
|
6 Participants
n=44 Participants
|
|
Sex: Female, Male
Male
|
38 Participants
n=44 Participants
|
|
Region of Enrollment
Thailand
|
44 Participants
n=44 Participants
|
PRIMARY outcome
Timeframe: an expected average of 2 weeksPopulation: Twenty-one Lugol's voiding lesions larger than 5mm were detected in 12 patients.
Diagnostic performance of the pCLE and M-NBI in Lugol's voiding lesions size larger than 5 millimeters.
Outcome measures
| Measure |
Study Arm
n=21 Lugol's voiding lesion
Probe-based confocal laser endomicroscopy and narrow band imaging with magnification in esophageal Lugol's voiding lesions.
|
|---|---|
|
Accuracy
dNBI
|
70 Percentage of accuracy
Interval 48.0 to 85.0
|
|
Accuracy
pCLE
|
89 Percentage of accuracy
Interval 67.0 to 97.0
|
Adverse Events
Study Arm
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Study Arm
n=44 participants at risk
Probe-based confocal laser endomicroscopy and narrow band imaging with magnification in esophageal Lugol's voiding lesions.
|
|---|---|
|
Surgical and medical procedures
Bleeding
|
2.3%
1/44 • Number of events 1 • Intraprocedural.
|
Additional Information
Dr. Piyapan Prueksapanich
Division of Gastroenterology. Department of Medicine. Faculty of Medicine. Chulalongkorn University.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place